Human spleen as a source of T cell growth factor

Area of Science:

• Immunology
• Cell Biology
• Biochemistry

Background:

• T cell growth factor (TCGF) is crucial for T cell proliferation and function.
• Peripheral blood leukocytes (PBL) are a known source of TCGF, but spleen cells have not been extensively studied.
• Understanding alternative sources of TCGF could enhance immunotherapy strategies.

Purpose of the Study:

• To compare the TCGF production capacity of human spleen cells versus peripheral blood leukocytes (PBL).
• To investigate the characteristics of spleen cells responsible for TCGF production.
• To evaluate the efficacy of spleen cell-derived TCGF in promoting the proliferation and cytotoxic activity of immune cells against cancer.

Main Methods:

• Human spleen cells and PBL were stimulated with phytohemagglutinin (PHA).
• Quantitative analysis was performed to measure TCGF levels in culture supernatants.
• Spleen cell fractions (TG-depleted and TG-enriched) were assessed for TCGF production.
• TCGF-treated mixed leukocyte-tumor cell culture (MLTC) blast cells were analyzed for proliferation and lytic activity against myelogenous leukemia cells.

Main Results:

• Spleen cell cultures produced approximately five times more TCGF than PBL cultures.
• TCGF production was consistent across individual spleen cell populations, unlike PBL.
• TG-depleted splenic T cell fractions showed superior TCGF production compared to TG-enriched fractions.
• Spleen cell-derived TCGF induced a ~300-fold increase in MLTC blast cell numbers and an ~80-fold increase in their cancer-killing activity within 7 days.

Conclusions:

• Human spleen cells are a more potent source of TCGF than PBL.
• Specific splenic T cell subsets are key contributors to TCGF production.
• Spleen cell-derived TCGF holds significant potential for enhancing anti-leukemia immune responses.